Potential role of cinnamon in the prevention and management of diabetic vascular complications in humans

被引:0
|
作者
Girgiss, Mina Wassef [1 ]
Nicola, Wassef Girgiss [2 ]
Habib, Dawoud Fakhry [3 ]
Youness, Eman Refaat [3 ]
Ahmed, Nadia Mohamed [3 ]
Elnemr, Mohamed Elsayed [4 ]
机构
[1] NRC, Med Div, Dept Complementary Med, Cairo, Egypt
[2] NRC, Med Div, Dept Internal Med, Cairo, Egypt
[3] NRC, Med Div, Med Biochem Dept, Cairo, Egypt
[4] 6th October Univ, Fac Med, Dept Internal Med, Giza, Egypt
来源
BIOSCIENCE RESEARCH | 2018年 / 15卷 / 01期
关键词
Cinnamon; Type 2 diabetes mellitus; Paraoxonase-1; Malondialdehyde; Cholesterol; Apo Cs; Vascular tree;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Experimental and human studies proved cinnamon to have some biological activities like those of insulin hormone. It increases glucose uptake by the different cells and increases glycogen storage. It targets PPAR a and. nuclear receptors which affect lipid and carbohydrate metabolism. Also it possesses antioxidant effects. We aim to study the effect of cinnamon on the vascular tree in obese type 2 diabetic patients. Sixteen obese type 2 diabetic female patients, each of them was given 1.8 gm of cinnamon powder in capsule form daily in three divided doses for three weeks. Their fasting serum paraoxonase-1, malondialdehyde, total cholesterol, LDL, HDL, Apo C II and Apo C lll were estimated before and after three consecutive weeks of cinnamon intake. Cinnamon significantly increased paraoxonase-1 and reduced malondialdehyde. It reduced total cholesterol, LDL cholesterol and increased HDL cholesterol. Again, it significantly reduced Apo C ll and decreased Apo C lll. In Conclusion cinnamon can be used as a supplementary agent in the management of atherosclerotic risk conditions such as obesity, type 2 diabetes mellitus, hypertension and dyslipidemia. Cinnamon tackled several important facets in the process of atherogenesis. It improved the oxidative stress, the lipid profile and the inflammatory state.
引用
收藏
页码:348 / 356
页数:9
相关论文
共 50 条
  • [21] The role of vascular endothelial growth factor in the progression of diabetic vascular complications
    Mahdy, R. A.
    Nada, W. M.
    Hadhoud, K. M.
    El-Tarhony, S. A.
    EYE, 2010, 24 (10) : 1576 - 1584
  • [22] The role of vascular endothelial growth factor in the progression of diabetic vascular complications
    R A Mahdy
    W M Nada
    K M Hadhoud
    S A El-Tarhony
    Eye, 2010, 24 : 1576 - 1584
  • [23] Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications
    Yamagishi, Sho-ichi
    Ueda, Seiji
    Nakamura, Kazuo
    Matsui, Takanori
    Okuda, Seiya
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (25) : 2613 - 2618
  • [24] The Role of Oxidative Stress in the Pathogenesis of Diabetic Vascular Complications
    Sasaki, Shuji
    Inoguchi, Toyoshi
    DIABETES & METABOLISM JOURNAL, 2012, 36 (04) : 255 - 261
  • [25] A novel role of complement in the pathogenesis of diabetic vascular complications
    Acosta, JA
    Hettinga, J
    Flÿkiger, R
    Goldfine, AB
    Halperin, JA
    CIRCULATION, 2000, 102 (18) : 50 - 50
  • [26] Tips and tricks in the prevention and management of vascular complications in TAVI
    Tommasino, Antonella
    Sirignano, Pasqualino
    Dell'Aquila, Federico
    Fiorentini, Vincenzo
    Casenghi, Matteo
    Giovannelli, Francesca
    Rigattieri, Stefano
    Berni, Andrea
    Taurino, Maurizio
    Barbato, Emanuele
    CIRUGIA CARDIOVASCULAR, 2025, 32 (02): : 93 - 101
  • [27] Surgical prevention and management of vascular complications of kidney transplantation
    Bessede, Thomas
    Droupy, Stephane
    Hammoudi, Yacine
    Bedretdinova, Dina
    Durrbach, Antoine
    Charpentier, Bernard
    Benoit, Gerard
    TRANSPLANT INTERNATIONAL, 2012, 25 (09) : 994 - 1001
  • [28] The vascular complications of diabetes: a review of their management, pathogenesis, and prevention
    Meir, Juliet
    Huang, Lillian
    Mahmood, Sumaita
    Whiteson, Harris
    Cohen, Scott
    Aronow, Wilbert S.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2024, 19 (01) : 11 - 20
  • [29] The Role of GRK2 and Its Potential as a New Therapeutic Target in Diabetic Vascular Complications
    Taguchi, Kumiko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (08): : 961 - 967
  • [30] Diabetic vascular complications
    Cooper, ME
    Gilbert, RE
    Jerums, G
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10): : 770 - 775